{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:01:51Z","timestamp":1775570511440,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"DOI":"10.7759\/cureus.102910","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:14:08Z","timestamp":1770142448000},"source":"Crossref","is-referenced-by-count":1,"title":["Cephalexin-Induced Autoimmune Hemolytic Anemia: A Case Report"],"prefix":"10.7759","author":[{"given":"Jesse","family":"Albano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hemolytic anemia","volume":"69","author":"Dhaliwal G","year":"2004","unstructured":"Dhaliwal G, Cornett PA, Lawrence M, Tierney J. Hemolytic anemia. Am Fam Physician. 2004, 69:2599-2607.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-00208-7","article-title":"Autoimmune hemolytic anemia: current knowledge and perspectives","volume":"17","author":"Michalak SS","year":"2020","unstructured":"Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, et al.. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing. 2020, 17:38. 10.1186\/s12979-020-00208-7","journal-title":"Immun Ageing"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14654","article-title":"Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia","volume":"177","author":"Hill QA","year":"2017","unstructured":"Hill QA, Stamps R, Massey E, et al.. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017, 177:208-20. 10.1111\/bjh.14654","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000405","article-title":"Warm autoimmune hemolytic anemia and the best treatment strategies","volume":"2022","author":"Kuter DJ","year":"2022","unstructured":"Kuter DJ. Warm autoimmune hemolytic anemia and the best treatment strategies. Hematology Am Soc Hematol Educ Program. 2022, 2022:105-13. 10.1182\/hematology.2022000405","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPBVLJZH6W6RQM","article-title":"Pathology consultation on drug-induced hemolytic anemia","volume":"136","author":"Pierce A","year":"2011","unstructured":"Pierce A, Nester T. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol. 2011, 136:7-12. 10.1309\/AJCPBVLJZH6W6RQM","journal-title":"Am J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","author":"Garratty G","year":"2009","unstructured":"Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009, 73-9. 10.1182\/asheducation-2009.1.73","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000440673","article-title":"Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre","volume":"42","author":"Mayer B","year":"2015","unstructured":"Mayer B, Bartolm\u00e4s T, Y\u00fcrek S, Salama A. Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother. 2015, 42:333-9. 10.1159\/000440673","journal-title":"Transfus Med Hemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009801","article-title":"Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study","volume":"8","author":"Maquet J","year":"2024","unstructured":"Maquet J, Lafaurie M, Michel M, et al.. Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study. Blood Adv. 2024, 8:817-26. 10.1182\/bloodadvances.2023009801","journal-title":"Blood Adv"},{"key":"ref9","article-title":"Hemolytic Anemia Resulting From Immune Injury","author":"Packman CH","year":"2021","unstructured":"Packman CH. Hemolytic Anemia Resulting From Immune Injury. Kaushansky K, Prchal JT, Burns LJ, et al. (ed): McGraw-Hill Education, 2021."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12542","article-title":"Cephalexin-induced haemolytic anaemia: A case report","volume":"42","author":"Thiessen K","year":"2017","unstructured":"Thiessen K, Kraleti S. Cephalexin-induced haemolytic anaemia: A case report. J Clin Pharm Ther. 2017, 42:615-7. 10.1111\/jcpt.12542","journal-title":"J Clin Pharm Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.152","article-title":"The Case | Acute renal failure after antibiotic treatment for bronchitis","volume":"87","author":"Baradhi KM","year":"2015","unstructured":"Baradhi KM, Ahmed S, Buford ML. The Case | Acute renal failure after antibiotic treatment for bronchitis. Kidney Int. 2015, 87:1269-70. 10.1038\/ki.2014.152","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1987.tb133379.x","article-title":"Cephalexin-induced haemolytic anaemia","volume":"147","author":"Manoharan A","year":"1987","unstructured":"Manoharan A, Kot T. Cephalexin-induced haemolytic anaemia. Med J Aust. 1987, 147:202. 10.5694\/j.1326-5377.1987.tb133379.x","journal-title":"Med J Aust"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.48.557.186","article-title":"Acute intravascular haemolysis associated with cephalexin therapy","volume":"48","author":"Forbes CD","year":"1972","unstructured":"Forbes CD, Craig JA, Mitchell R, McNicol GP. Acute intravascular haemolysis associated with cephalexin therapy. Postgrad Med J. 1972, 48:186-8. 10.1136\/pgmj.48.557.186","journal-title":"Postgrad Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-504","article-title":"Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone-a case study approach","volume":"18","author":"Arndt PA","year":"2002","unstructured":"Arndt PA. Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone-a case study approach. Immunohematology. 2002, 18:27-32.","journal-title":"Immunohematology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2008.05.001","article-title":"Hemolytic anemia from ceftriaxone in an elderly patient: a case report","volume":"9","author":"Imam SN","year":"2008","unstructured":"Imam SN, Wright K, Bhoopalam N, Choudhury A. Hemolytic anemia from ceftriaxone in an elderly patient: a case report. J Am Med Dir Assoc. 2008, 9:610-1. 10.1016\/j.jamda.2008.05.001","journal-title":"J Am Med Dir Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-018-0257-7","article-title":"Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature","volume":"19","author":"Leicht HB","year":"2018","unstructured":"Leicht HB, Weinig E, Mayer B, et al.. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature. BMC Pharmacol Toxicol. 2018, 19:67. 10.1186\/s40360-018-0257-7","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s001340000598","article-title":"Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature","volume":"26","author":"Seltsam A","year":"2000","unstructured":"Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med. 2000, 26:1390-4. 10.1007\/s001340000598","journal-title":"Intensive Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam allergy","volume":"6","author":"Zagursky RJ","year":"2018","unstructured":"Zagursky RJ, Pichichero ME. Cross-reactivity in \u03b2-lactam allergy. J Allergy Clin Immunol Pract. 2018, 6:72-81.e1. 10.1016\/j.jaip.2017.08.027","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1517\/14740330802577351","article-title":"Drug-induced immune hemolytic anemia","volume":"8","author":"Salama A","year":"2009","unstructured":"Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf. 2009, 8:73-9. 10.1517\/14740330802577351","journal-title":"Expert Opin Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427783-cephalexin-induced-autoimmune-hemolytic-anemia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:14:09Z","timestamp":1770142449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427783-cephalexin-induced-autoimmune-hemolytic-anemia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102910","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}